谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

[Tisagenlecleucel for Relapsed/refractory Diffuse Large B-cell Lymphoma: Real-World Data from Single Institute Experience].

Yu Yagi,Yusuke Kanemasa,Yuki Sasaki,Yudai Hayashi,Mano Mino,Chika Kato,Satoshi Sakai,An Ohigashi,Yasuhiro Kanbara,Yuka Morita,Taichi Tamura,Yuya Atsuta,Ryosuke Konuma,Shohei Nakamura,Atsushi Wada,Toshihiro Okuya,Akihiko Kageyama,Daisuke Murakami,Shiori Nakashima,Yusuke Uchibori,Daishi Onai,Atsushi Hamamura,Akihiko Nishijima,Yasushi Omuro,Naoki Shingai,Takuya Shimizuguchi,Takashi Toya,Hiroaki Shimizu,Yuho Najima,Takeshi Kobayashi,Kyoko Haraguchi,Kazuteru Ohashi,Noriko Doki,Yoshiki Okuyama,Tatsu Shimoyama

PubMed（2022）

引用 0|浏览26
暂无评分
关键词
Chimeric antigen receptor T-cell therapy,Real-world data,Relapse/refractory diffuse large B-cell lymphoma,Tisagenlecleucel
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要